Path to FDA Approval
A Final Report for the Phase I Lung Cancer trial was filed – Ann Thorac Surg. 2004; 77(6):1916
A Final Report for the Phase I Ovarian Cancer trial is expected to be submitted to the FDA in the 3rd Quarter of 2020
With FDA approval, Verthermia is ready to begin treatments within 60-90 days.